Vicore Pharma Holding AB Sponsored ADR (VCRE) Financial Statements

2 Followers

Vicore Pharma Holding AB Sponsored ADR Financial Overview

Vicore Pharma Holding AB Sponsored ADR's market cap is currently $263.57M. The company's EPS TTM is $-9.404; its P/E ratio is -10.12; Vicore Pharma Holding AB Sponsored ADR is scheduled to report earnings on August 21, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25
Income Statement
Total Revenue	kr 3.82M
Gross Profit	kr 3.82M
Operating Income	kr -454.44M
EBITDA	kr -477.41M
Net Income	kr -477.47M
Balance Sheet
Cash & Short-Term Investments	kr 1.17B
Total Assets	kr 1.22B
Total Debt	kr 0.00
Net Debt	kr -578.15M
Total Liabilities	kr 123.17M
Stockholders' Equity	kr 1.10B
Cash Flow
Free Cash Flow	kr -375.74M
Operating Cash Flow	kr -375.74M
Investing Cash Flow	kr -600.51M
Financing Cash Flow	kr 430.54M

Currency in SEK

Vicore Pharma Holding AB Sponsored ADR Earnings and Revenue History

Income Statement >

Vicore Pharma Holding AB Sponsored ADR Debt to Assets

Balance Sheet >

Vicore Pharma Holding AB Sponsored ADR Cash Flow

Cash Flow >

Vicore Pharma Holding AB Sponsored ADR Forecast EPS vs Actual EPS

Earnings >